Watchful Waiting & Prostate Cancer
/Over 90 percent of prostate cancers are detected at a curable stage, with men more likely to die of other diseases than from this cancer.
Read MoreOver 90 percent of prostate cancers are detected at a curable stage, with men more likely to die of other diseases than from this cancer.
Read MoreThe PHI test is a new blood test that may eventually replace the PSA test when testing for prostate cancer. It is a simple, noninvasive blood test that is three times more specific than PSA in detecting prostate cancer. Controversy remains surrounding the use of the PSA test to screen for prostate cancer. This is due to the belief that the PSA test may lead to over-diagnosis and over-treatment in men with low-grade, less aggressive forms of the disease.
Read MoreCould obesity be to blame for the higher rates of prostate cancer in African American men? According to a new study from the University Of Washington School Of Nursing and the Fred Hutchinson Cancer Research Center in Seattle – yes, obesity might play a role.
Read MoreThis year at the 110th Annual Scientific Meeting of the American Urological Association (AUA), four new studies will be presented which examine different approaches to what researchers believe are smarter methods to screen for prostate cancer.
Controversy remains surrounding the use of the PSA test to screen for prostate cancer. This is due to the belief that the PSA test may lead to over-diagnosis and over-treatment in men with low-grade, less aggressive forms of the disease. Clinicians have been long awaiting a new approach to screen for prostate cancer because the current PSA test is simply not accurate enough.
Read MoreA new study shows a correlation between baldness and prostate cancer.
Read MoreWe've come a long way. There have been many innovations when it comes to prostate cancer detection. Here's what men need to be aware of.
Read More